May MIMS update
The latest in medicines news from MIMS, including new products, indications, contraindications and presentations New products Elacestrant (dihydrochloride) (Orserdu) is an orally active estrogen receptor (ER)‑α antagonist and degrader. Elacestrant inhibits the …
Different pathways, same promise
The healthcare landscape is shifting fast – and with that shift comes with the question, what should today’s pharmacy graduates look like? Australian Pharmacy Council (APC) chief executive, Bronwyn Clark …
Pharmacist prescriber or pharmacist practitioner?
Pharmacist practitioner Kate Gunthorpe takes a look at why the language we use matters Over the past few years, the term “pharmacist prescriber” has rapidly entered our professional and public …
Looking at Budget 2026
The 2026–27 Federal Budget introduced several significant proposals for tax reform writes Peak Strategies’ accountant manager, Marcus Evitt Outlined below are some pharmacy-related measures announced; however, unlike last year’s federal budget, …
What the 2026 Federal Budget means for health
Reforms to the NDIS, which are set to deliver $37.8 billion in savings, dominate the health side of the Federal Budget, experts from NAB say Despite the energy shock and …
Dandruff is more than a cosmetic issue
New national research highlights a clear role for pharmacy in addressing the issue of dandruff. The Heads Up, Australia! survey of over 1,000 dandruff sufferers revealed the true impact. 87% …
AI more than a novelty
Everyone’s jumping on the AI trend… but pharmacy owners are missing its biggest opportunity, writes Peak Strategies’ accountant Patricia Aditopo You’ve likely seen it everywhere lately. Social feeds filled with AI-generated caricatures …
Product news for May 2026
FluMist: flu protection without the injection In 2024, more than 2300 children were hospitalised in Australia with influenza, with almost half younger than 5 years.1 Previously healthy children can experience …
April MIMS update
Some of the recent changes to the medicines landscape, with new products and indications New Products Fedratinib (as dihydrochloride monohydrate) (Inrebic) is an oral kinase inhibitor with activity against wild …
AI in pharmacy practice
Artificial intelligence (AI) is becoming increasingly embedded in practice, write PDL professional officers, Kylie Neville and Amy Minion While it offers opportunities to improve efficiency and consistency, AI also introduces …
Payday super is coming
Victoria Le from Peak Strategies outlines what every business owner needs to prepare for ahead of the implementation of payday super Super is a key part of Australia’s retirement system …
Why HMRs are rapidly reaching crisis point
PSA national president Professor Mark Naunton explains how flexibility, access and equity will prevent the fuel crisis from lurching into a health emergency Nearly two million Australians regularly take at …